Community/Retail

CVS Health has announced that the company's specialty pharmacy has been awarded Specialty Pharmacy accreditation from URAC.

Everything possible should be done for those with autism.

Drug therapy must balance the potential to improve quality of life with the risk of adverse effects. In the context of ever-increasing treatment complexity, striking this balance is getting complicated.

The FDA approved defibrotide sodium (Defitelio) for the treatment of hepatic veno-occlusive disease in adults and children who have additional kidney or lung abnormalities following hematopoietic stem cell transplantation.

Walgreens' community pharmacist intervention program boosts medication adherence rates and lowers related costs for patients with a wide range of chronic diseases, a recent study demonstrated.

Ohio Northern University student Taylor Lewis has been appointed to the National Community Pharmacists Association Student Leadership Council for a 2-year term.

The phone interview may not win you the job, but it can often lose you the job.

The main lessons to learn from rejection are to understand that it happens, know not to take it personally, and use it to grow professionally.

Drug abuse has been in the news in a big way lately.

The University of Connecticut Student Societies of Health-System Pharmacy is striving to get more individuals to donate blood and bone marrow through an organization called Delete Blood Cancer DKMS.

After total knee replacement surgery, patients younger than 45 years and those aged 75 years or older seem to report more pain and less activity than their peers.

A pharmacy in Michigan was recently robbed by a thief wielding a sledgehammer.

Bayer is expanding its involvement with refugees in Germany with two additional initiatives at the company's Berlin site.

Walgreens pharmacy patients offered a multi-faceted medication adherence program demonstrated 3% greater medication adherence and significantly lower healthcare spending, according to a new study.

Three studies published last year provide useful information on risk factors for colds, which affect adults 2 to 3 times a year.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses why it is important that patients know which medication they should use in a particular situation.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses some ways pharmacists can improve patient adherence to novel oral anticoagulants.

It turns out Reliable Drug Pharmacy's products may not be so reliable after all.

The Generic Pharmaceutical Association and its Biosimilars Council are pleased that the Food and Drug Administration (FDA) has issued its draft guidance on biosimilar labeling.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses counseling points for both anticoagulant classes.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Student pharmacists from across the country were recently honored for their outstanding efforts in preventing prescription medication misuse as part of Generation Rx, an ongoing education and outreach initiative created by the Cardinal Health Foundation.

The Kroger Co. has announced a strategic partnership with Lucky's Market, a specialty grocery store chain focused on natural, organic and locally-grown products.

Mindful exercise, eating, and stress-reducing practices could help obese patients reduce their diabetes risk.

What patients don't know about their prescription medications can hurt them.

When asking patients what medications they take, many often only acknowledge daily prescription medications.

Vitamin D supplementation may help boost patients' immune responses, especially in winter months.

The FDA has approved Glenmark Pharmaceuticals Inc's abbreviated new drug application for raloxifene hydrochloride tablets USP, 60 mg, which is the therapeutic equivalent to Eli Lilly and Company's Evista.

Dennis Williams, PharmD, FAPhA, discusses the steps pharmacists should take when a patient does not see relief from first-line therapies.

Have you ever considered pursuing a post-graduate year 2 pharmacy residency in neurology?